表紙
市場調查報告書

心臟標記分析儀的全球市場:產品分析,公司業務/營銷策略,主要交易

Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals

出版商 iGate Research Pvt Ltd 商品編碼 949233
出版日期 內容資訊 英文 118 Pages
訂單完成後即時交付
價格
心臟標記分析儀的全球市場:產品分析,公司業務/營銷策略,主要交易 Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals
出版日期: 2020年07月14日內容資訊: 英文 118 Pages
簡介

到2026年,全球心臟標記分析儀市場預計將達到45億美元。作為一種診斷範例,心臟標記分析儀可以在幾分鐘內提供敏感而可靠的信息,使其既適合即時檢驗也適合實驗室使用。諸如心血管疾病的發病率增加,人口激增的老齡化,公共和私人組織對心臟生物標誌物研究的資金增加以及正在進行的臨床試驗以識別市場上新的心臟生物標誌物等因素。它正在推動增長。但是,諸如與樣本收集和存儲有關的技術問題以及與監管和贖回系統有關的問題等因素是阻礙市場增長的一些主要障礙。

該報告調查了全球心臟標記分析儀市場,並提供了有關市場趨勢和預測,COVID-19的影響,競爭格局以及主要公司的產品/趨勢/策略分析的信息。

內容

第1章執行摘要

第2章COVID-19的影響

第三章市場與預測(2011-2026)

第4章心臟標記公司:比較測試分析

第5章競爭對手分析

第6章Alere(現為Abbott)

  • Alere分診
    • Alere Cardiology 淨銷售額(2010-2016)

第7章Quidel Corporation

  • Quidel Triage system
    • Quidel Cardiac Immunoassay 淨銷售額(2017-2026)

第8章Abbott Point of Care

  • i-STAT系統
  • Abbott Laboratories Point of Care Diagnostics 淨銷售額(2011-2026)

第9章Roche

  • Cobas h 232 POC System

第10章 Beckman Coulter

  • Access 2 Immunoassay System

第11章Siemens Healthineers

  • Stratus CS Analyzer
  • Siemens Healthineers:建立全球數位生態系統,促進醫療保健的數位化

第12章Response Biomedical

  • 心血管檢查
    • 急性心肌梗塞(心臟病)測試
    • 充血性心力衰竭(CHF)測試
    • 血栓形成試驗
  • RAMP平台
    • RAMP 200
    • RAMP Reader
  • 響應心血管測試
    • RAMP;肌鈣蛋白I
    • RAMP; NT-proBNP
    • RAMP;肌紅蛋白
    • RAMP; CK-MB
    • RAMP; D-DIMER
    • 響應心血管測試的淨銷售額(2010-2026)

第13章Boditech

  • i-chroma DUO Analyzer

第14章Lifesign

  • DXpress Reader Analyzer

第15章LSI Medience Corporation

  • PATHFAST Analyzer

第16章CardioGenics Holdings Inc.

  • QL Care Analyzer

第17章Trinity Biotech

  • Meritas POC Analyzer
  • Trinity Biotech Point of Care Diagnostics淨銷售額(2010-2019)

第18章合併,收購和許可協議

  • Alere Inc
  • CardioGenics
  • Response Biomedical
  • Abbott Laboratories
  • Siemens Healthineers
  • LSI Medience Corporation
  • Trinity Biotech
  • Quidel

第19章新標記

第20章Response Biomedical:商業和營銷策略

  • 在中國的新代理商
  • 與日本Alere Medical結成戰略聯盟
  • Response Biomedical:加拿大衛生部批准和CE標誌
  • 專注於提高效率和降低成本

第21章Roche:業務和營銷策略

  • 完全連接的核心實驗室實施
  • 羅氏(Roche):宣佈提高準確性的即時護理(POC)肌鈣蛋白測試
  • 羅氏(Roche):宣佈平板電腦的新移動應用程序

第22章Boditech Med Inc:業務和營銷策略

  • Boditech Med收購免疫學
  • 多元化的營銷渠道

第23章 Siemens Healthineers:業務和營銷策略

  • Siemens Healthineers:Teamplay Digital Health Platform發佈
  • Siemens Healthineers:宣佈新的戰略關係
  • Siemens與Imricor之間的戰略聯盟
  • Siemens Healthineers:提供高度敏感的肌鈣蛋白I IVD分析
  • Siemens Healthineers:建立促進醫療保健數位化的全球數位生態系統
  • Siemens Healthineers和Ebit聯盟
目錄

The global Cardiac Marker Analyzer market is predicted to reach US$ 4.5 Billion by 2026. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.

Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The factors such as increasing incidences of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are some of the key factors hampering the growth of this market.

Key Highlights of the Report

  • In October 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016.
  • Abbott Point of Care Diagnostics sales is driven by continued adoption of Abbott's i-STAT handheld system.
  • Quidel's cardiac immunoassay revenue was valued around US$ 266.5 Million in 2019.
  • Cobas H232 POC system permits rapid and easy determination of cardiac blood markers such as Troponin T, NT-proBNP, D-dimer, CK-MB and myoglobin.
  • A major focus of Response Biomedical development programs in cardiovascular testing has been clinical tests for the quantification of cardiovascular markers.
  • Response Biomedical sells tests that detect three of the primary markers for the detection of an acute myocardial infarction: Troponin I, Myoglobin and CK-MB.
  • In March 2020, Siemens Healthineers announced market introduction of the teamplay digital health platform.
  • CardioGenics is the only company to successfully deploy CL in a compact, fully automated POC platform.
  • Abbott acquired St. Jude Medical, to reap benefits of the latter's strong global position in thriving cardiac areas such as heart failure, atrial fibrillation, structural heart, and chronic pain complement.
  • Trinity Biotech Point-of-Care revenues declined in 2019 by around 23.2% from the previous year figure.
  • In October 2017, Boditech Med has made an agreement with their Chinese distributor, Joinstar, to supply their products for US$ 48 Million over three years.

iGATE RESEARCH report titled "Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals" provides a comprehensive assessment of the cardiac marker analyzer segments, comparative tests analysis, competitive product analysis, product features & benefits, merger & acquisitions, strategic alliances and Companies Business and Market Strategies.

This 118 Page report with 10 Figures and 19 Tables has been studied from 7 View Points:

  • 1. Cardiac Marker Analyzer Market & Forecast (2011 - 2026)
  • 2. Cardiac Marker Companies - Comparative Tests Analysis
  • 3. Cardiac Marker Analyzer - Competitive Product Analysis
  • 4. Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis
  • 5. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
  • 6. Emerging Markers Analysis
  • 7. Companies Business & Marketing Strategy

The Cardiac Marker Analyzer Covered in the report are as follows:

  • 1. Triage MeterPro Analyzer
  • 2. The i-STAT System
  • 3. Cobas h 232 POC System
  • 4. Access 2 Immunoassay System
  • 5. Stratus CS Analyzer
  • 6. RAMP 200
  • 7. RAMP Reader
  • 8. i-chroma DUO Analyzer
  • 9. Dxpress Reader Analyzer
  • 10. PATHFAST Analyzer
  • 11. QL Care Analyzer
  • 12. Meritas POC Analyzer

Cardiac Marker Analyzer - Key Company Analysis

  • 1. Alere (Now Abbott)
  • 2. Abbott Point of Care
  • 3. Quidel Corporation
  • 4. Roche
  • 5. Beckman Coulter
  • 6. Siemens Healthineers
  • 7. Response Biomedical
  • 8. Boditech
  • 9. Lifesign
  • 10. LSI Medience Corporation
  • 11. CardioGenics Holdings Inc.
  • 12. Trinity Biotech

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

  • Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
  • Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Cardiac Marker Analyzer Market

3. Global Cardiac Marker Analyzer Market & Forecast (2011-2026)

4. Cardiac Marker Companies-Comparative Tests Analysis

5. Cardiac Marker Analyzer-Competitive Product Analysis

6. Alere (Now Abbott)

  • 6.1. Alere Triage
    • 6.1.1. Alere Cardiology Net Sales (2010-2016)

7. Quidel Corporation

  • 7.1. Quidel Triage system
    • 7.1.1. Quidel Cardiac Immunoassay Net Sales (2017-2026)

8. Abbott Point of Care

  • 8.1. The i-STAT System
  • 8.2. Abbott Laboratories Point of Care Diagnostics Sales (2011-2026)

9. Roche

  • 9.1. Cobas h 232 POC System

10. Beckman Coulter

  • 10.1. Access 2 Immunoassay System

11. Siemens Healthineers

  • 11.1. Stratus CS Analyzer
  • 11.2. Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

12. Response Biomedical

  • 12.1. Cardiovascular Testing
    • 12.1.1. Acute Myocardial Infarction (Heart Attack) Testing
    • 12.1.2. Congestive Heart Failure ("CHF") Testing
    • 12.1.3. Thrombotic Disease Testing
  • 12.2. RAMP Platform
    • 12.2.1. RAMP 200
    • 12.2.2. RAMP Reader
  • 12.3. Response Cardiovascular Testing
    • 12.3.1. RAMP® TROPONIN I
    • 12.3.2. RAMP® NT-proBNP
    • 12.3.3. RAMP® MYOGLOBIN
    • 12.3.4. RAMP® CK-MB
    • 12.3.5. RAMP® D-DIMER
    • 12.3.6. Response Biomedical Cardiovascular Net Sales (2010-2026)

13. Boditech

  • 13.1. i-chroma DUO Analyzer

14. Lifesign

  • 14.1. DXpress Reader Analyzer

15. LSI Medience Corporation

  • 15.1. PATHFAST Analyzer

16. CardioGenics Holdings Inc.

  • 16.1. QL Care Analyzer

17. Trinity Biotech

  • 17.1. Meritas POC Analyzer
  • 17.2. Trinity Biotech Point of Care Diagnostics Sales (2010-2019)

18. Mergers, Acquisitions and Licensing Agreements

  • 18.1. Alere Inc
  • 18.2. CardioGenics
  • 18.3. Response Biomedical
  • 18.4. Abbott Laboratories
  • 18.5. Siemens Healthineers
  • 18.6. LSI Medience Corporation
  • 18.7. Trinity Biotech
  • 18.8. Quidel

19. Emerging Markers

20. Response Biomedical-Business & Marketing Strategy

  • 20.1. New Distributors in China
  • 20.2. Strategic Alliances with Alere Medical in Japan
  • 20.3. Response Biomedical Receives Health Canada Approval and CE Mark
  • 20.4. Focus on Improving Efficiencies and Reducing Costs

21. Roche-Business & Marketing Strategy

  • 21.1. Implementing the Fully Connected Core Laboratory
  • 21.2. Roche Launches Point-Of-Care (POC) Troponin Test with Improved Accuracy
  • 21.3. Roche Launches New Mobile Application for Tablets

22. Boditech Med Inc-Business and Marketing Strategy

  • 22.1. Boditech Med Acquires Immunostics
  • 22.2. Diversifying Marketing Channel

23. Siemens Healthineers-Business and Marketing Strategy

  • 23.1. Siemens Healthineers Introduces Teamplay Digital Health Platform
  • 23.2. Siemens Healthineers Announces New Strategic Relationship
  • 23.3. Strategic Partnership between Siemens and Imricor
  • 23.4. Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay
  • 23.5. Siemens Healthineers Establishes Global Digital Ecosystem to Drive Digitalization of Healthcare
  • 23.6. Partnership between Siemens Healthineers and Ebit

List of Figures:

  • Figure 3-1: Global - Cardiac Marker Analyzer Market (Million US$), 2011 - 2019
  • Figure 3-2: Global - Forecast for Cardiac Marker Analyzer Market (Million US$), 2020 - 2026
  • Figure 6-1: Global - Alere Cardiology Net Sales (Million US$), 2010 - 2016
  • Figure 7-1: Quidel - Cardiac Immunoassay Revenue (Million US$), 2017 - 2019
  • Figure 7-2: Quidel - Forecast for Cardiac Immunoassay Revenue (Million US$), 2020 - 2026
  • Figure 8-1: Global - Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 - 2019
  • Figure 8-2: Global - Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2020 - 2026
  • Figure 12-1: Global - Response Biomedical Cardiovascular Product Sales (Million US$), 2010 - 2019
  • Figure 12-2: Global - Forecast for Response Biomedical Cardiovascular Product Sales (Million US$), 2020 - 2026
  • Figure 17-1: Global - Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2010 - 2019

List of Tables:

  • Table 4-1: Cardiac Marker Companies - Comparative Tests Analysis
  • Table 4-2: Cardiac Marker Companies - Comparative Tests Analysis
  • Table 4-3: Cardiac Marker Companies - Comparative Tests Analysis
  • Table 5-1: Cardiac Marker Analyzer - Competitive Product Analysis
  • Table 5-2: Cardiac Marker Analyzer - Competitive Product Analysis
  • Table 6-1: Alere - Triage Product Analytes
  • Table 15-1: PATHFAST - Technical Specifications
  • Table 18-1: Alere - Merger & Acquisition, 2007 - 2017
  • Table 18-2: Alere - Distribution/Partnership Agreement, 2008, 2016
  • Table 18-3: CardioGenics - Mergers & Acquisition, 2015
  • Table 18-4: CardioGenics - Licensing Agreement, 2012
  • Table 18-5: Response Biomedical - Distribution Agreement, 2011 - 2015
  • Table 18-6: Response Biomedical - Collaboration Deal, 2004 - 2015
  • Table 18-7: Abbott Laboratories - Merger & Acquisition, 2003, 2017, 2019
  • Table 18-8: Siemens Healthineers - Merger & Acquisition, 2017
  • Table 18-9: Siemens Healthineers - Strategic Partnership, 2017
  • Table 18-10: LSI Medience Corporation - Strategic Alliance, 2014
  • Table 18-11: Trinity Biotech - Merger & Acquisition, 2012
  • Table 18-12: Quidel Corporation - Merger & Acquisition, 2017